In vitro activity of Fluoroquinolones against Mycobacterium tuberculosis

被引:58
|
作者
Sulochana, S [1 ]
Rahman, F [1 ]
Paramasivan, CN [1 ]
机构
[1] ICMR, TB Res Ctr, Madras 600031, Tamil Nadu, India
关键词
Mycobacterium tuberculosis; fluoroquinolones; lomefloxacin; ofloxacin; ciprofloxacin; sparfloxacin; moxifloxacin; gatifloxacin;
D O I
10.1179/joc.2005.17.2.169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The in vitro activity of fluoroquinolones, including lomefloxacin, ofloxacin, ciprofloxacin, sparfloxacin, moxifloxacin and gatifloxacin, was evaluated against 55 clinical isolates of Mycobacterium tuberculosis by absolute concentration method on Lowenstein-Jensen (L-J) and Middlebrook's 7H11 media. Both ofloxacin susceptible and ofloxacin resistant strains of M. tuberculosis isolates were tested. The in vitro activities of these fluoroquinolones on the M. tuberculosis isolates were in the order: lomefloxacin < ciprofloxacin < ofloxacin < sparfloxacin < moxifloxacin=gatifloxacin. Gatifloxacin and moxifloxacin showed low minimal inhibitory concentrations (MIC) for both ofloxacin resistant and ofloxacin susceptible strains even though some cross resistances were observed.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 50 条
  • [41] In vitro activity of rifabutin and rifampin against clinical isolates of Mycobacterium tuberculosis in Taiwan
    Chien, HP
    Yu, MC
    Ong, TF
    Lin, TP
    Luh, KT
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2000, 99 (05) : 408 - 411
  • [42] Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis
    Bettencourt, MV
    Bosne-David, S
    Amaral, L
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (01) : 69 - 71
  • [43] IN VITRO ACTIVITY OF P,P'-DIAMINODIPHENYL SULPHONE (DDS) AGAINST MYCOBACTERIUM TUBERCULOSIS
    GUPTA, SK
    JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH, 1961, C20 (06): : 173 - &
  • [44] In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates
    Erturan, Z
    Uzun, M
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (01) : 78 - 80
  • [45] Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
    Sayadi, Mahdieh
    Zare, Hosna
    Jamedar, Saeed Amel
    Hashemy, Seyed Isaac
    Meshkat, Zahra
    Soleimanpour, Saman
    Hoffner, Sven
    Ghazvini, Kiarash
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [46] Novel fluoroquinolones:: design, synthesis, and in vivo activity in mice against Mycobacterium tuberculosis H37Rv
    Shindikar, AV
    Viswanathan, CL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) : 1803 - 1806
  • [47] Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis
    Hu, YM
    Coates, ARM
    Mitchison, DA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) : 653 - 657
  • [48] Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones
    Basarab, Gregory S.
    Ghorpade, Sandeep
    Gibhard, Liezl
    Mueller, Rudolf
    Njoroge, Mathew
    Peton, Nashied
    Govender, Preshendren
    Massoudi, Lisa M.
    Robertson, Gregory Thomas
    Lenaerts, Anne J.
    Boshoff, Helena Ingrid
    Joerss, Douglas
    Parish, Tanya
    Durand-Reville, Thomas F.
    Perros, Manos
    Singh, Vinayak
    Chibale, Kelly
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (04)
  • [49] Investigation of 6-fluoroquinolones activity against Mycobacterium tuberculosis using theoretical molecular descriptors: a case study
    Minovski, Nikola
    Jezierska-Mazzarello, Aneta
    Vracko, Marjan
    Solmajer, Tom
    CENTRAL EUROPEAN JOURNAL OF CHEMISTRY, 2011, 9 (05): : 855 - 866
  • [50] Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
    Mahdieh Sayadi
    Hosna Zare
    Saeed Amel Jamedar
    Seyed Isaac Hashemy
    Zahra Meshkat
    Saman Soleimanpour
    Sven Hoffner
    Kiarash Ghazvini
    BMC Infectious Diseases, 20